BTBT vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

BTBT

47.6
AI Score
VS
HIVE Wins

HIVE

48.3
AI Score

Investment Advisor Scores

BTBT

48score
Recommendation
HOLD

HIVE

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BTBT HIVE Winner
Forward P/E 23.8663 62.8931 BTBT
PEG Ratio 0 0 Tie
Revenue Growth 25.6% 73.5% HIVE
Earnings Growth 0.0% -99.9% BTBT
Tradestie Score 47.6/100 48.3/100 HIVE
Profit Margin -240.2% -98.5% HIVE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BTBT 1M: +8.9% · 3M: -8.1% HIVE 1M: +10.6% · 3M: -20.1%

Current Technical Phase

BTBT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.1 · Price: $1.59

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.8 · Price: $3.03

Fundamentals Snapshot

Metric BTBT HIVE
Market Cap
Forward P/E -9.9 -5.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.3% 0.7%
Gross Margin 0.6% 0.4%
Operating Margin -2.4% -0.6%
EPS -0.79 -1.33
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.